U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
115981115981Septic Shock em SteroidsRecruitingNo Results AvailableMechanical Ventilation|MortalityDrug: Hydrocortisonehttps://ClinicalTrials.gov/show/NCT01047670
115982115982Effects of Weight Loss in Obese Difficult-to-treat AsthmaticsCompletedNo Results AvailableAsthma|Obesity|Weight LossBehavioral: Low caloric diet plus orlistat and sibutraminehttps://ClinicalTrials.gov/show/NCT01047657
115983115983Port Will be Flushed Every 3 Months Instead of Every 4-6 Wks, as Recommended by Port Manufacturer.RecruitingNo Results AvailableComplication of CatheterOther: Reduced port-flush schedulehttps://ClinicalTrials.gov/show/NCT01047644
115984115984Role of Exercise in Diastolic Heart FailureCompletedNo Results AvailableDiastolic Heart Failure|Heart Failure With Preserved Ejection FractionBehavioral: Functional circuit training and lifestyle counseling|Behavioral: Health education and independent walkinghttps://ClinicalTrials.gov/show/NCT01047631
115985115985Venous Thromboembolism in Advanced Gastric Cancer PatientsCompletedNo Results AvailableAdvanced Gastric Cancerhttps://ClinicalTrials.gov/show/NCT01047618
115986115986Pharmacological Effects of Neurapas® Balance and Pascoflair® 425 mg on Brain Activity in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Neurapas balance|Drug: Pascoflair 425 mg|Drug: P-Tabletten weißhttps://ClinicalTrials.gov/show/NCT01047605
115987115987Treatment of N-methyl-D-aspartate (NMDA) Enhancers for SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: sarcosine|Drug: sarcosine+ BE|Drug: placebohttps://ClinicalTrials.gov/show/NCT01047592
115988115988A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer's DiseaseDrug: Rivastigmine transdermalhttps://ClinicalTrials.gov/show/NCT01047579
115989115989Effect of Addition of Dronedarone to Standard Rate Control Therapy on Ventricular Rate During Persistent Atrial Fibrillation (AFRODITE)CompletedNo Results AvailableAtrial FibrillationDrug: Dronedarone|Drug: Beta blocker or calcium antagonist or digoxinhttps://ClinicalTrials.gov/show/NCT01047566
115990115990Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedHas ResultsChronic Obstructive Pulmonary DiseaseDrug: Formoterol (OT)https://ClinicalTrials.gov/show/NCT01047553
115991115991Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2CompletedNo Results AvailableHSV-2Drug: AIC316|Drug: AIC316|Drug: AIC316|Drug: AIC316|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01047540
115992115992An Effectiveness Trial of Maintenance Therapy for Nicotine DependenceCompletedHas ResultsNicotine DependenceDrug: Transdermal nicotine patchhttps://ClinicalTrials.gov/show/NCT01047527
115993115993Healthier Living CanadaCompletedNo Results AvailableAsthma|Chronic DiseaseBehavioral: Chronic Disease Self-Management Online Workshophttps://ClinicalTrials.gov/show/NCT01047514
115994115994Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and - CompletedNo Results AvailableHypertriglyceridemiaDrug: AMR101 (ethyl icosapentate)|Drug: AMR101 (ethyl icosapentate)|Drug: Placebo|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01047501
115995115995Imipramine and Pregabalin Combination in Painful PolyneuropathyNot yet recruitingNo Results AvailablePolyneuropathyDrug: Imipramine|Drug: Pregabalin|Drug: Imipramine, pregabalin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01047488
115996115996A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer (FDA IND 103675)CompletedHas ResultsColorectal CancerDrug: MB-6|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01047475
115997115997Scandinavian Diverticulitis TrialActive, not recruitingNo Results AvailableDiverticulitisProcedure: Surgery for acute perforated diverticulitishttps://ClinicalTrials.gov/show/NCT01047462
115998115998Improving the Results of Heart Bypass Surgery Using New Approaches to Surgery and MedicationActive, not recruitingNo Results AvailableCoronary Artery DiseaseProcedure: No-touch SVG harvest vs conventional SVG harvest technique|Dietary Supplement: Fish oil supplementation vs placebohttps://ClinicalTrials.gov/show/NCT01047449
115999115999Efficacy of ArTiMistâ„¢ in ChildrenCompletedHas ResultsFalciparum MalariaDrug: Quinine|Drug: Artemetherhttps://ClinicalTrials.gov/show/NCT01047436
116000116000Targeting Microvascular Dysfunction in Young Hypertensive PatientsRecruitingNo Results AvailableHypertensionDrug: Simvastatin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01047423
116001116001ACtive Care After TransplantationRecruitingNo Results AvailablePost-transplant Weight GainOther: Exercise intervention|Other: Exercise intervention and dietary advicehttps://ClinicalTrials.gov/show/NCT01047410
116002116002Repeat Dose Safety and Efficacy Study for Compound to Treat AnemiaCompletedNo Results AvailableKidney DiseaseDrug: 1278863A|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01047397
116003116003Management of Postoperative Pain Following Total Knee Arthroplasty by Using Acupuncture-moxibustion TherapyCompletedNo Results AvailableOsteoarthritis, KneeProcedure: acupuncture-moxibustion therapy|Procedure: Regular therapyhttps://ClinicalTrials.gov/show/NCT01047384
116004116004Why in Hospital - Factors Determining Time to Discharge Readiness After Arthroplasty SurgeryCompletedNo Results AvailablePain|Nausea|Vomiting|Dizzyness|Fatigue|Organizational Concerns|Ect.https://ClinicalTrials.gov/show/NCT01047371
116005116005Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast CancerCompletedHas ResultsBreast CancerDrug: Aromasin|Drug: Aromasinhttps://ClinicalTrials.gov/show/NCT01047358
116006116006A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASILâ„¢ (V503-006)Active, not recruitingHas ResultsCervical Cancers|Vulvar Cancers|Vaginal Cancers|Genital WartsBiological: V503|Biological: Placebo to V503https://ClinicalTrials.gov/show/NCT01047345
116007116007A Trial Comparing the Uncovered to the Covered Wallstent in the Palliation of Malignant Bile Duct StricturesActive, not recruitingNo Results AvailableInoperable Tumors of the Bile DuctDevice: Wallstent|Device: Non-Covered Wallstenthttps://ClinicalTrials.gov/show/NCT01047332
116008116008A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple SclerosisActive, not recruitingNo Results AvailableRelapsing Multiple SclerosisDrug: Laquinimodhttps://ClinicalTrials.gov/show/NCT01047319
116009116009A Study of Patients With Sanfilippo Syndrome Type A (MPS IIIA)CompletedNo Results AvailableSanfilippo Syndrome Type AOther: assessmenthttps://ClinicalTrials.gov/show/NCT01047306
116010116010RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal CarcinomaActive, not recruitingNo Results AvailableColorectal CancerDrug: RAD011|Drug: FOLFOX|Drug: Bevacizumabhttps://ClinicalTrials.gov/show/NCT01047293

* Görseller ve İçerik tekif hakkına sahip olabilir